Skip to content

Investigation on HPV infection and HPV vaccination willingness among men who have sex with men in Tianjin

Investigation on HPV infection and HPV vaccination willingness among men who have sex with men in Tianjin

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077380
Enrollment
Unknown
Registered
2023-11-07
Start date
2023-11-10
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV

Interventions

HIV positive MSM:N/A
HIV negative MSM:N/A
Heterosexual male:N/A

Sponsors

Tianjin Centers for Disease Control and Prevention
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: (Estimated sample size of 1500 people) 1. HIV-positive MSM: Males aged >= 18 years who have engaged in anal or oral sex with men in the past year; either infected with HIV or patients. Sample sourced from the Infectious Diseases Department of Tianjin Second People's Hospital; sample size of 300 people; 2. HIV-negative MSM: Males aged >= 18 years who have engaged in anal or oral sex with men in the past year and are HIV antibody-negative. Sample sourced from social organization network recruitment or MSM community event venues; sample size of 600 people; 3. Heterosexual Males: Males aged >= 18 years who have engaged in vaginal, anal, or oral sex with women in the past year. Sample sourced from medical institutions' urology/STD clinics and other male patients; sample size of 600 people.

Exclusion criteria

Exclusion criteria: 1. Previously vaccinated with any type of HPV vaccine, including bivalent, quadrivalent, or nonavalent; 2. Never engaged in sexual activity; 3. Underwent other surgical procedures on genital, anal, or oral areas within the last six months, excluding wart removal; 4. Participated in other drug clinical trials within the last six months; 5. Unable to cooperate in completing swab samples from all three areas; 6. Other conditions deemed unsuitable for inclusion by the researchers.

Design outcomes

Primary

MeasureTime frame
HPV nucleic acid detection;HPV vaccination intention questionnaire;

Countries

China

Contacts

Public ContactYu Maohe

Tianjin Centers for Disease Control and Prevention

yumaohe@tj.gov.cn+86 138 2118 1011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026